Biotech & MedTech News
-
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Switzerland
January 30, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt
January 27, 2023 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) announces that, further to its news release…
-
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office
January 26, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Sona Nanotech to Acquire Cancer Therapy Developer Siva Therapeutics
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Valeo Pharma Announces Filing of a New Drug Submission-COVID 19 With Health Canada for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients
In the final analysis of the Phase 3 cinical study conducted by Veru Inc., sabizabulin showed a 51.6%…
-
Valeo Pharma to Host Fourth Quarter and Year-End 2022 Results Conference Call / Webcast
January 25, 2023 (Source) – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Hemostemix Wins Arbitration Decision
January 24, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Sixth Wave Innovations Inc. Adds Peruvian Patent to Their Growing MIPs ‘Metals Extraction’ IP Portfolio
January 24, 2023 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Amended: Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement
January 23, 2023 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) announces that, further to its news…
-
Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs
January 23, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
